Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |